Andrew Combs - Dec 13, 2021 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
EVP, Head of Chemistry
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
Stock symbol
PRLD
Transactions as of
Dec 13, 2021
Transactions value $
$94,880
Form type
4
Date filed
12/15/2021, 04:21 PM
Previous filing
Jul 22, 2021
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRLD Common Stock Purchase $48.5K +4K +1.54% $12.12 264K Dec 13, 2021 Direct F1
transaction PRLD Common Stock Purchase $46.4K +4K +1.51% $11.60 268K Dec 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.